胃癌根治性切除术后患者CT影像组学特征的预后价值
该回顾性研究纳入181例接受根治性切除术的胃癌患者,评估由6个影像特征构成的影像组学标签(R-signature)与总生存期的关联,并在验证队列中验证。整合R-signature与显著临床病理危险因素(T分期、N分期、分化程度)的影像组学列线图预后优于临床列线图及单独R-signature。
要点
- R-signature由6个影像特征构成,可将根治性切除术后胃癌患者分为高、低预后风险两组。
- 整合R-signature与T分期、N分期、分化程度的影像组学列线图预后优于临床列线图及单独R-signature。
- 影像组学可能有助于个性化治疗决策和患者咨询。
核心结论
- R-signature可用于将根治性切除术后的胃癌患者分层为高风险组和低风险组。
- 影像组学列线图提供比其他预测模型更好的预测准确性,可能有助于临床医生的治疗决策和患者咨询。
研究设计与样本
- 回顾性研究,共纳入181例接受根治性切除术的胃癌患者。
- 在主要队列中评估R-signature与总生存期的关联,并在验证队列中验证。
- 评估整合R-signature与显著临床病理危险因素的影像组学列线图的性能。
诊断标准与关键数值
- R-signature由六个影像特征组成,将患者分为两个预后风险组。
- 影像组学列线图整合R-signature与显著临床病理危险因素(T分期、N分期、分化程度)。
- Harrell一致性指数:影像组学列线图0.82 vs 临床列线图0.71(p < 0.001),影像组学列线图0.82 vs 单独R-signature 0.74(p < 0.001)。
- 所有校准曲线显示预测生存与实际生存高度一致,决策曲线分析验证了影像组学列线图在临床实践中的实用性。
临床应用与阅片要点
- R-signature可用于对根治性切除术后的胃癌患者进行高、低风险分层。
- 影像组学列线图整合R-signature与T分期、N分期、分化程度,预测准确性优于临床列线图及单独R-signature。
- 影像组学列线图可能有助于临床医生的治疗决策和患者咨询。
- 影像组学可提高TNM分期系统的预后价值。
- 影像组学可能促进胃癌患者的个性化治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The present study aimed to investigate the clinical prognostic significance of radiomics signature (R-signature) in patients with gastric cancer who had undergone radical resection.
METHODS: A total of 181 patients with gastric cancer who had undergone radical resection were enrolled in this retrospective study. The association between the R-signature and overall survival (OS) was assessed in the primary cohort and verified in the validation cohort. Furthermore, the performance of a radiomics nomogram integrating the R-signature and significant clinicopathological risk factors was evaluated.
RESULTS: The R-signature, which consisted of six imaging features, stratified patients with gastric cancer who had undergone radical resection into two prognostic risk groups in both cohorts. The radiomics nomogram incorporating R-signature and significant clinicopathological risk factors (T stage, N stage, and differentiation) exhibited significant prognostic superiority over clinical nomogram and R-signature alone (Harrell concordance index, 0.82 vs 0.71 and 0.82 vs 0.74, respectively, p < 0.001 in both analyses). All calibration curves showed remarkable consistency between predicted and actual survival, and decision curve analysis verified the usefulness of the radiomics nomogram for clinical practice.
CONCLUSIONS: The R-signature could be used to stratify patients with gastric cancer following radical resection into high- and low-risk groups. Furthermore, the radiomics nomogram provided better predictive accuracy than other predictive models and might aid clinicians with therapeutic decision-making and patient counseling.
KEY POINTS: • Radiomics can stratify the gastric cancer patients following radical resection into high- and low-risk groups. • Radiomics can improve the prognostic value of TNM staging system. • Radiomics may facilitate personalized treatment of gastric cancer patients.
引用
- Li W, Zhang L, Tian C, et al. Prognostic value of computed tomography radiomics features in patients with gastric cancer following curative resection. Eur Radiol. 2018. PMID: 30519931. doi:10.1007/s00330-018-5861-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。